Lifeboat Foundation

In perhaps the most unexpected tech news of the year, billionaire and AI evangelist Sam Altman has been ejected from his CEO role at OpenAI by the company’s board after an apparent vote of no confidence. Its exact wording in a release issued this afternoon: Altman’s “departure follows a deliberative review process by the board, which concluded that he was not consistently candid in his communications with the board, hindering its ability to exercise its responsibilities.”

What the hell is happening at the most hyped company in the world?! Here are some totally speculative theories that occurred to us and others around the web.

Sierra Space, one of the sector’s most valuable private companies, laid off several hundred employees and contractors this week, CNBC has learned.

A Sierra Space spokesperson confirmed the company let go of about 165 employees on Thursday, but declined to specify the number of contractors affected. Former Sierra Space employees told CNBC that the layoffs included a significant number of contractors, with the cuts including hundreds of personnel in total.

The laid-off employees received two weeks of paid non-working notice, plus four weeks of severance pay and health care benefits through the end of the year. Sierra Space had about 2,000 employees before reducing its workforce, the company spokesperson said.

The devices demonstrated clinical-grade accuracy and introduced novel functionalities not seen in prior research or clinical care.

Northwestern University.

Furthering the scope of such examinations, a team of researchers at Northwestern University (NU) is now presenting novel wearable technology much more advanced than the intermittent measures made during periodic medical examinations.

Continue reading “Wearable device harnesses body sounds for continuous health monitoring” »

Get a blood test, check blood pressure, and swab for aliments — all without a doctor or nurse.

Adrian Aoun, CEO and co-founder of Forward Health, aims to scale healthcare.

Adrian Aoun, CEO and co-founder of Forward Health, aims to scale healthcare. It started in 2017 with the launch of tech-forward doctor’s offices that eschewed traditional medical staffing for technology solutions like body scanners, smart sensors, and algorithms that can diagnose ailments. Now, in 2023, he’s still on the same mission and rolled up all the learnings and technology found in the doctor’s office into a self-contained, standalone medical station called the CarePod.

Continue reading “Forward Health launches CarePods, a self-contained, AI-powered doctor’s office” »

YouTube will soon make users add a disclaimer when they post artificial intelligence-generated or manipulated videos.

In a company blog post, the video giant outlined its forthcoming rule change that will not only require a warning label, but will display disclaimers larger for certain types of “sensitive” content such as elections and public health crises.

As Bloomberg reports, this change at the Alphabet-owned company comes after a September announcement that election ads across the firm’s portfolio will require “prominent” disclosures if manipulated or generated by AI — a rule that’s slated to begin mid-November, the outlet previously reported.

Throughout history, sonar’s distinctive “ping” has been used to map oceans, spot enemy submarines and find sunken ships. Today, a variation of that technology – in miniature form, developed by Cornell researchers – is proving a game-changer in wearable body-sensing technology.

PoseSonic is the latest sonar-equipped wearable from Cornell’s Smart Computer Interfaces for Future Interactions (SciFi) lab. It consists of off-the-shelf eyeglasses outfitted with micro sonar that can track the wearer’s upper body movements in 3D through a combination of inaudible soundwaves and artificial intelligence (AI).

With further development, PoseSonic could enhance augmented reality and virtual reality, and track detailed physical and behavioral data for personal health, the researchers said.

Boston, MA—We’ve known for more than a century that women outlive men. But new research led by Harvard T.H. Chan School of Public Health and UC San Francisco shows that, at least in the United States, the gap has been widening for more than a decade. The trend is being driven by the COVID-19 pandemic and the opioid overdose epidemic, among other factors.

In a research paper, to be published online on November 13 in JAMA Internal Medicine, the authors found the difference between how long American men and women live increased to 5.8 years in 2021, the largest it’s been since 1996. This is an increase from 4.8 years in 2010, when the gap was at its smallest in recent history.

The pandemic, which took a disproportionate toll on men, was the biggest contributor to the widening gap from 2019–2021, followed by unintentional injuries and poisonings (mostly drug overdoses), accidents, and suicide.

The connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race.

Now, a new Harvard Medical School study published in Science Immunology may offer a molecular explanation behind this century-old observation.

The study, in mice, suggests that the beneficial effects of exercise may be driven, at least partly, by the immune system. It shows that muscle inflammation caused by exertion mobilizes inflammation-countering T cells, or Tregs, which enhance the muscles’ ability to use energy as fuel and improve overall exercise endurance.

Psychiatric patients almost twice as likely to have multiple physical ailments – new study.

A new study, conducted by Anglia Ruskin University (ARU) in collaboration with the University of Cambridge’s Biomedical Research Centre, has revealed significant findings about the physical health of psychiatric patients. This extensive analysis incorporated data from 19 different studies, involving 194,123 psychiatric patients globally, and compared them to 7,660,590 individuals in control groups.

Findings on Multimorbidity.